Hormonal contraception and HIV: consensus statement.
A study published in 2004 on a cohort of sex workers followed over many years in Mombasa, Kenya, showed that users of hormonal contraception have a 1.5-fold (combined oral contraceptives [COCs]) to 1.8-fold (depot-medroxyprogesterone acetate [DMPA]) higher risk of acquiring HIV infection compared with non-users. Other studies conducted among sex workers have found similarly elevated risks. Two new studies, one in Uganda, Thailand and Zimbabwe, the other in South Africa, that are pending publication, conducted among family planning service users, found no overall increase in risk of acquiring HIV infection in women who used hormonal contraception compared with women who used non-hormonal contraception or no contraceptive method.
The meeting recommended that there should be no restrictions on the use of oral contraception and DMPA by women at risk of acquiring HIV, consistent with the current WHO Medical Eligibility Criteria for Contraceptive Use guidelines. However, participants suggested that the Guidelines Steering Group reconsider its classification regarding women at high individual risk of HIV infection, for whom some caution on use of these methods may be appropriate. The meeting reiterated the importance of promotion of condom use and called for training for family planning providers in promoting use of dual protection against STIs/HIV and unwanted pregnancy. (1)
(1.) Hormonal contraception and HIV: science and policy. Statement (final), September 2005.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||ROUND UP: HIV/AIDS|
|Publication:||Reproductive Health Matters|
|Date:||Nov 1, 2005|
|Previous Article:||Evidence that male circumcision reduces HIV acquisition may be flawed.|
|Next Article:||Global midwifery training programme on HIV/AIDS launched.|